Evernorth Invests $100 Million in AI-Powered Specialty Pharmacy Program

Evernorth, the health services division of The Cigna Group, has launched a new AI-powered program for specialty pharmacy called Pharmacy Forward. Backed by a $100 million investment through 2028, this initiative aims to improve patient care by leveraging advanced technologies in four key areas: care enablement, experience accelerators, Rx readiness, and operational efficiency.

Evernorth serves over 190 million people globally, providing comprehensive pharmacy, care, and benefits solutions. Pharmacy Forward is initially being rolled out through Accredo Specialty Pharmacy, which supports approximately 1 million patients with chronic and complex conditions. Matt Perlberg, president of Evernorth’s Health Services pharmacy and care delivery businesses, highlighted the program's potential to transform patient experiences.

Enhancing Clinical Outcomes

One of the primary goals of Pharmacy Forward is to enhance clinical outcomes by providing real-time insights and predictive analytics. The program uses AI to identify patients at risk of adverse events and enables early intervention. According to Perlberg, this technology can significantly reduce the administrative burden on clinicians, allowing them to focus more on patient care.

“About 15% of our clinicians’ time is spent on administrative tasks,” Perlberg said in an interview. “Pharmacy Forward will help us reduce that burden, so our clinicians can get back to what they do best-taking care of patients.”

The program also includes AI-enabled scheduling tools that ensure patients are contacted during their preferred call windows, personalizing the care experience and improving patient engagement. Pharmacy Forward supports prior authorization submissions and copay assistance eligibility, streamlining these processes and reducing wait times for patients.

Market Verdict

Evernorth’s investment in AI-powered solutions reflects a broader trend in healthcare technology, where advanced analytics and machine learning are increasingly being used to improve operational efficiency and patient outcomes. The $100 million commitment underscores Cigna's strategic focus on leveraging technology to enhance its services and competitive position.

According to Reuters, the program is expected to cut the time it takes for patients to receive their medication after a referral by half. This reduction in wait times can have significant implications for patient satisfaction and overall health outcomes, particularly for those managing chronic conditions.

The success of Pharmacy Forward could also set a precedent for other healthcare providers and insurers looking to adopt similar technologies. As AI continues to mature and more data becomes available, the potential for further innovation in specialty pharmacy is substantial.

Evernorth’s $100 million investment in Pharmacy Forward represents a strategic move to enhance patient care through advanced technology. By reducing administrative burdens, personalizing care experiences, and streamlining medication access, this program has the potential to significantly improve outcomes for patients with complex conditions.